

Context   
**Business Requirements Document (BRD)**

**Project ID:** COM-TRANSP-001 **Project Name:** Physician Payment and Transparency Reporting System **Date:** October 7, 2025 **Purpose:** To develop a cloud-native, commercial software solution for pharmaceutical and medical device companies to track, report, and disclose payments and other transfers of value (ToV) to healthcare professionals (HCPs) and organizations (HCOs), ensuring compliance with global transparency regulations.

---

### **1\. Business Goals**

* **Ensure Regulatory Compliance:** Provide a solution that automates reporting to meet the requirements of various national and international transparency laws, including the U.S. Sunshine Act and the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code. This is critical for avoiding penalties and legal consequences.  
* **Increase Operational Efficiency:** Reduce the manual burden on compliance and finance teams by automating data capture, categorization, and report generation.  
* **Enhance Data Accuracy and Trust:** Implement features that allow for data verification, dispute resolution, and public-facing transparency to build trust with regulators, HCPs, and the public.  
* **Support Global Operations:** The system must be scalable and flexible to handle multi-currency transactions and diverse country-specific reporting requirements.

---

### **2\. Functional Requirements**

#### **2.1 Core System Functions**

* **Payment & ToV Capture (via Payment Capture API):** The system must accept and process a variety of payment and transfer of value data from multiple sources.  
  * **REQ-001:** The system must track financial interactions, including consulting fees, speaking fees, honoraria, research grants, royalties, and travel and lodging expenses.  
  * **REQ-002:** The system must capture transaction details such as date, value, currency, and the specific HCP or HCO recipient.  
  * **REQ-003:** The system must automatically categorize each ToV based on pre-defined criteria (e.g., General Payment, Research Payment, Ownership/Investment Interest).  
* **HCP/HCO Data Management (via HCP Data Management feature):** The system must maintain a comprehensive and accurate database of covered recipients.  
  * **REQ-004:** The system must store and manage HCP data including name, specialty, professional license number(s), and primary business address.  
  * **REQ-005:** The system must support the verification of HCP data against authoritative sources, such as the National Provider Identifier (NPI) database in the US.  
* **Compliance Rule Engine (via ToV Calculation API):** The system must apply specific rules for each reporting jurisdiction.  
  * **REQ-006:** The system must calculate the total value of payments made to each HCP and HCO for a given reporting period.  
  * **REQ-007:** The system must apply minimum reporting thresholds, such as the **$10** per-payment and **$100** aggregate annual thresholds under the US Sunshine Act.  
  * **REQ-008:** The system must support **multi-currency** transactions and convert all payment values to a single reporting currency (e.g., USD, EUR) using a defined exchange rate.  
* **Consent Management (via Physician Consent Management feature):** The system must manage and track HCP consent for public disclosure.  
  * **REQ-009:** The system must provide a mechanism for companies to obtain and record consent from HCPs as required by regulations like the EFPIA Disclosure Code.  
  * **REQ-010:** The system must manage different disclosure types, including **individual disclosure** (when consent is given) and **aggregate disclosure** (when consent is not given).  
* **Reporting & Submission (via Aggregate Reporting and CMS Open Payments APIs):** The system must generate compliant reports and facilitate submission to regulatory bodies.  
  * **REQ-011:** The system must generate reports that meet the specific formatting and data requirements for each jurisdiction. This includes both **aggregate reports** (for US Open Payments) and **individual disclosures** (for European countries).  
  * **REQ-012:** The system must provide a secure and automated method for direct submission of data to the **CMS Open Payments** system in the United States.  
* **Dispute Resolution Workflow (via Dispute Resolution feature):** The system must facilitate a process for HCPs to review and dispute reported data.  
  * **REQ-013:** The system must provide HCPs with a **45-day review period** to access and dispute their reported data before public release.  
  * **REQ-014:** The system must provide a clear workflow for companies and HCPs to communicate and resolve disputes, including the ability for the company to make corrections.  
* **Public Disclosure Website (via Disclosure Website Generation feature):** The system must generate a publicly accessible website to display reported data.  
  * **REQ-015:** The system must generate a website that complies with legal requirements for public disclosure, such as the French "Loi Bertrand" or the UK's Disclosure UK system, which often require data to be published on a central platform or the company's website.

---

### **3\. Non-Functional Requirements**

* **Security:** The system must be cloud-native and have robust security protocols to protect sensitive HCP data.  
* **Scalability:** The architecture must be scalable to handle a large volume of transactions and a growing number of HCPs and clients.  
* **Usability:** The user interface should be intuitive for compliance, finance, and sales teams to easily input, manage, and report data.  
* **Integration:** The system must be able to seamlessly integrate with a variety of external systems including CRM, expense, payroll, and event management systems via the defined APIs.  
* **Pricing:** The pricing model will be based on a **"Per HCP interaction \+ reporting"** structure. This must be a core component of the system's billing and usage tracking.

---

### **4\. Sources for Rules and Regulations 📚**

* **Sunshine Act / Open Payments (US):**  
  * **Official Law:** The Physician Payments Sunshine Act, enacted as part of the Affordable Care Act (ACA). The official rules are codified in **42 CFR Part 403, Subpart I** of the Code of Federal Regulations.  
  * **Governmental Body:** The Centers for Medicare & Medicaid Services (CMS) administers the Open Payments program. Their official website, `cms.gov/openpayments`, is the primary source for program details, user guides, and data.  
  * **Industry Guidance:** The American Medical Association (AMA) provides resources and guidance for physicians on how to understand and interact with the Open Payments program.  
* **EFPIA Disclosure Code (EU):**  
  * **Self-Regulatory Body:** The European Federation of Pharmaceutical Industries and Associations (EFPIA) maintains the Disclosure Code, which is a set of self-regulatory standards for its member companies.  
  * **Legal Framework:** The collection and use of personal data under the code must comply with the EU's General Data Protection Regulation (GDPR) and national data protection laws.  
  * **Disclosure Rules:** The code mandates disclosure of payments to HCPs and HCOs, often with a focus on individual disclosure when consent is obtained.  
* **National Transparency Laws (France, UK, etc.):**  
  * **France (Loi Bertrand):** France has mandatory reporting legislation that requires the public disclosure of payments and agreements with HCPs and HCOs.  
  * **United Kingdom:** While the UK has the voluntary Disclosure UK database managed by the Association of the British Pharmaceutical Industry (ABPI), there is ongoing governmental consultation about introducing mandatory reporting legislation similar to the US and France.

To build a truly robust system, you need to "double-click" further into the granular details and variations of each regulatory framework. Here is a more complete breakdown of the rules, including nuances and recent updates that a transparency reporting system must handle.

### **1\. U.S. Sunshine Act (Open Payments)**

**Core Principle:** A federally mandated law (part of the Affordable Care Act) requiring applicable manufacturers of drugs, devices, and biologics to report payments and transfers of value to covered recipients. The data is published annually on a public website by the Centers for Medicare & Medicaid Services (CMS).

#### **Key Details:**

* **Covered Recipients:**  
  * Physicians (doctors of medicine, osteopathy, dentists, podiatrists, optometrists, and chiropractors).  
  * **Crucial Update:** The **SUPPORT Act** expanded the definition to include Physician Assistants, Nurse Practitioners, Clinical Nurse Specialists, Certified Registered Nurse Anesthetists, and Certified Nurse Midwives. Your system must be able to track and report to these expanded categories.  
  * Teaching Hospitals.  
* **Reportable Payments/ToV:**  
  * **General Payments:** Fees for services (consulting, speaking), food and beverages, travel, gifts, honoraria, and educational materials. The **$10 per-payment** and **$100 aggregate annual threshold** are critical for flagging payments.  
  * **Research Payments:** Any payment made in connection with a research agreement, including grants and funding for clinical trials. These are reported under a separate category.  
  * **Ownership/Investment Interest:** Any equity, stock, or other ownership interest held by a physician or their immediate family member.  
  * **Indirect Payments:** The system must track payments made to a third party (e.g., a medical education company) if the payment is directed or intended for a specific covered recipient.  
* **Non-Reportable (Exempt) Payments:**  
  * Educational materials that are directly for patient use.  
  * Product samples intended for patient use.  
  * Discounts and rebates on products.  
  * Items of less than $10, unless the aggregate total to that recipient exceeds $100 annually.  
* **Reporting Cycle & Submission Nuances:**  
  * **Reporting Period:** Data is collected for a full calendar year (January 1 \- December 31).  
  * **Submission Window:** Applicable manufacturers must submit their data to CMS between February 1 and March 31 of the following year.  
  * **Dispute Resolution:** HCPs have a 45-day review period (usually from April to May) to review and dispute any reported data before final publication on June 30th.  
  * **Data Integrity:** CMS disallows record deletions without a substantiated reason. Your system's dispute workflow must handle record corrections and the justification for changes.

### **2\. EFPIA Disclosure Code (EU)**

**Core Principle:** A self-regulatory code adopted by EFPIA member companies. It emphasizes transparency in interactions with HCPs and Healthcare Organizations (HCOs), but is distinct from the US model due to its reliance on **consent** and the presence of numerous national variations.

#### **Key Details:**

* **Voluntary vs. Mandatory:** The EFPIA code itself is a self-regulatory commitment, but many member states have implemented national laws (e.g., in Portugal, France, and Denmark) that make disclosure mandatory. Your system needs to distinguish between these countries.  
* **Recipient Consent:** This is the most critical difference from the US. Companies must seek **freely given, specific, and unambiguous consent** from HCPs to individually disclose their data.  
  * **Individual Disclosure:** If consent is granted, the company publishes the named HCP and the value of the transfer.  
  * **Aggregate Disclosure:** If consent is not granted, the payment is reported in an aggregate sum alongside a count of the recipients.  
* **Reportable Payments/ToV:**  
  * **Direct Payments:** Fees for service, consultancy agreements, and payments for travel and accommodation to attend educational events.  
  * **Indirect Payments:** Transfers of value made via a third-party organization (e.g., a research institution or a conference organizer) are also reportable.  
  * **Donations and Grants:** Payments made to HCOs (not individuals) for research or educational purposes are reportable.  
  * **R\&D Exemption:** Payments for R\&D activities are generally disclosed on an **aggregate basis** to protect intellectual property and confidentiality.  
* **Non-Reportable (Exempt) Payments:**  
  * Inexpensive items of medical value.  
  * Meals and drinks, although national codes may set specific thresholds for these.  
  * Information and educational materials designed for patients.  
  * Over-the-counter medicine samples.  
* **Reporting Cycle & Submission Nuances:**  
  * **Reporting Period:** Annually, covering a full calendar year.  
  * **Publication Deadline:** The disclosure must be made public by June 30th of the following year.  
  * **Publication Platform:** In most countries, companies publish on their own website. However, some countries (e.g., France, Portugal, and Belgium) have national, governmental platforms where the data must be submitted. This variation is a significant design consideration for your system.

### **3\. French "Loi Bertrand"**

**Core Principle:** A mandatory, comprehensive transparency law that is broader than the US Sunshine Act in its scope of covered recipients and products.

#### **Key Details:**

* **Mandatory Disclosure:** All agreements and benefits must be publicly disclosed on a central government website, the "Transparence Santé" database.  
* **Covered Recipients:** This is a key point of differentiation. The law covers a very broad range of recipients, including:  
  * Physicians, pharmacists, nurses, and midwives.  
  * **Medical students.**  
  * **Scientific societies** and associations of healthcare professionals.  
  * **Consulting firms** that provide services to the healthcare sector.  
* **Reportable Payments/ToV:**  
  * Any benefit in cash or in-kind representing or exceeding **€10**.  
  * **All agreements**, including research and development contracts, consultancy agreements, and hospitality agreements for conventions.  
  * **No Obligation to Disclose:** A notable exception is that there is no obligation to disclose amounts for commercial sales agreements for goods and services.  
* **Submission & Publication:** Data for the first half of the year (Jan 1 \- June 30\) must be submitted by September 1st. Data for the second half of the year (July 1 \- Dec 31\) must be submitted by March 1st. The data is published for a period of five years.

### **4\. UK Disclosure UK**

**Core Principle:** A unique, voluntary, self-regulatory system managed by the Association of the British Pharmaceutical Industry (ABPI), acting as the UK's national implementation of the EFPIA Disclosure Code. There is no comprehensive, mandatory reporting law in the UK.

#### **Key Details:**

* **Voluntary Disclosure:** Disclosure UK is a central, voluntary database for the pharmaceutical industry. Participation is a requirement for ABPI members.  
* **Consent and Data Privacy:** Similar to the EFPIA model, the system is based on consent. Companies are "encouraged" to obtain consent for individual disclosure. If consent is not given, the value is published in an aggregated total.  
* **Recipient Categories:** The rules apply to HCPs and HCOs.  
* **What is Disclosed:**  
  * Payments for fees-for-service, sponsorship to attend meetings (travel, accommodation, registration), and grants/donations to HCOs.  
  * R\&D payments are reported in an aggregate lump sum, without individual recipient names.  
* **Variations:** Your system must be aware that other sectors, such as medical technology, do not have a single, unified reporting portal and may have to publish on their own company websites. There is no single, government-mandated system for all healthcare sectors.

To codify the business rules for payment transparency into a system, you need to translate the regulations into a structured data model and a set of logical rules. This involves several key steps that correspond to the APIs and features identified in the BRD.

### **1\. Data Model Design**

First, create a database schema that can store all the necessary information for a payment or a transfer of value (ToV).

* **Payment/ToV Table:** This is the core table.  
  * `payment_id` (Primary Key)  
  * `hcp_id` (Foreign Key to HCP table)  
  * `date_of_payment`  
  * `value` (Numeric field, e.g., in cents to avoid floating-point errors)  
  * `currency` (String, e.g., USD, EUR)  
  * `category` (e.g., "Consulting Fee," "Travel," "Gift")  
  * `description` (Free-text description of the expense)  
  * `source_system` (e.g., "Expense Management," "CRM")  
  * `is_reportable` (Boolean, calculated by the rules engine)  
  * `reporting_jurisdiction` (e.g., "US," "France," "UK")  
* **HCP (Healthcare Professional) Table:**  
  * `hcp_id` (Primary Key)  
  * `first_name`, `last_name`  
  * `npi_number` (For US reporting)  
  * `professional_license_number`  
  * `country_of_practice`  
  * `consent_for_disclosure` (Boolean, for EFPIA)  
* **Jurisdiction\_Rules Table:** This table stores the specific rules for each country.  
  * `jurisdiction_id` (e.g., "US\_Sunshine\_Act")  
  * `min_individual_threshold` (Numeric, e.g., 10 for US)  
  * `min_aggregate_threshold` (Numeric, e.g., 100 for US)  
  * `currency` (e.g., "USD")

---

### **2\. Implementing the Rules Engine (ToV Calculation API)**

The rules engine is the heart of the system. It takes raw payment data and applies the legal regulations to determine reportability. This can be built using a series of conditional statements or a more advanced rules engine framework.

#### **A. Initial Categorization and Flagging**

When a new payment record is created, the system must perform an initial check. This logic would be implemented in the `Payment Capture API` and trigger the `ToV Calculation API`.

Python  
def is\_initial\_reportable(payment):  
    \# Rule 1: General exemptions  
    if payment.category in \["Drug Sample", "Patient Education Material"\]:  
        return False  
    \# Rule 2: Check against low-value threshold (e.g., US Sunshine Act)  
    if payment.jurisdiction \== "US" and payment.value \< 1000:  \# Value is in cents  
        return "Maybe"  \# Requires aggregation check later  
    \# Rule 3: Check for France's specific threshold  
    if payment.jurisdiction \== "FR" and payment.value \< 1000:  
        return "Maybe"  
    \# Rule 4: All other cases are generally reportable  
    return True

#### **B. Aggregation Logic**

The system needs a scheduled process (e.g., a daily or weekly job) to perform aggregate calculations. This process would use the `HCP` and `Payment/ToV` tables.

* **Step 1:** Iterate through all **"Maybe"** payments for a specific jurisdiction (e.g., US).  
* **Step 2:** For each HCP, calculate the sum of all their low-value payments (`value < $10`).  
* **Step 3:** Apply the aggregate rule.

Python  
def check\_aggregate\_rules():  
    \# Example for US Sunshine Act  
    hcp\_data \= get\_hcp\_payments(jurisdiction="US")  
    for hcp in hcp\_data:  
        low\_value\_payments \= hcp.payments\_where(value \< 1000\)  
        total\_low\_value \= sum(p.value for p in low\_value\_payments)  
        if total\_low\_value \>= 10000: \# Total $100 or more  
            \# Update all "Maybe" payments for this HCP to "Reportable"  
            for payment in low\_value\_payments:  
                payment.is\_reportable \= True  
        else:  
            \# Update all "Maybe" payments to "Non-Reportable"  
            for payment in low\_value\_payments:  
                payment.is\_reportable \= False

#### **C. Jurisdiction-Specific Logic**

The rules engine must be designed to handle country-specific nuances.

* **EU (EFPIA):** The system must check the `consent_for_disclosure` flag. If `True`, the payment is marked for **Individual Disclosure**. If `False`, it's marked for **Aggregate Disclosure**.  
* **France (Loi Bertrand):** The system must not only flag the payment value but also be able to record and disclose the terms of any underlying agreement (e.g., a consultancy contract) in the `description` field.

---

### **3\. Reporting and Submission (Aggregate Reporting API)**

Once the `is_reportable` flag has been set for all payments, the system can generate the final reports.

* **US CMS Open Payments:**  
  * The system generates a single, formatted report (typically a `.csv` file in the specific CMS format) containing all payments flagged as `is_reportable = True` for the US jurisdiction.  
  * This file is then submitted via the **CMS Open Payments API**.  
* **EU Disclosure:**  
  * The system generates two sets of data:  
    * **Individual Data:** A list of HCPs and their payments where `consent_for_disclosure = True`.  
    * **Aggregate Data:** A total sum of all payments where `consent_for_disclosure = False`.  
  * This data is used to generate the public disclosure website as required by the EFPIA Code.

By breaking down the regulations into these three core components—**Data Model**, **Rules Engine**, and **Reporting Logic**—you can build a system that accurately and automatically manages payment transparency reporting for multiple global jurisdictions.

Double-clicking on the previous response, here are more detailed insights into the complexities of the system you're building, focusing on key regulatory differences and practical implementation challenges.

### **1\. The Nuance of Individual vs. Aggregate Disclosure**

The distinction between individual and aggregate disclosure is a central theme in global transparency reporting, particularly when comparing the US and European models.

* **Individual Disclosure:** This is the gold standard for transparency. It involves publishing detailed information on a public database, linking a specific payment or transfer of value to an individually named healthcare professional (e.g., "Dr. Jane Smith received $500 for a speaking engagement on June 1, 2025"). The U.S. Sunshine Act and France's "Loi Bertrand" are mandatory individual disclosure laws. The main goal is to promote transparency and help the public understand potential conflicts of interest.  
* **Aggregate Disclosure:** This involves publishing a lump sum of payments without identifying the individual recipients. For example, a report might state, "Company X paid a total of €50,000 to healthcare professionals in Spain who did not consent to individual disclosure." This method is used primarily in two scenarios:  
  * **EU (EFPIA):** Under the EFPIA Disclosure Code, companies must first seek a healthcare professional's **explicit consent** for individual disclosure. If consent is denied, the payment is disclosed on an aggregate basis. This is a crucial difference from the US model, which does not require consent. This highlights the strong influence of data privacy laws like GDPR in the EU.  
  * **Research & Development (R\&D):** Both the US and EFPIA models generally allow R\&D payments to be reported on an aggregate basis, acknowledging the confidential and often proprietary nature of research. This is a common and important exemption.

Your system's "Dispute Resolution Workflow" is vital because it's where the HCP can review the data before it becomes public, ensuring accuracy before the data is locked in for disclosure.

### **2\. The CMS Open Payments Submission Process**

The "CMS Open Payments Submission" feature isn't a simple API call like you might think. It's a structured and specific data submission process with its own unique challenges.

* **Not a Real-time API:** The CMS Open Payments system doesn't offer a live, real-time API for submissions. Instead, it operates on a defined, annual cycle. Companies must collect data throughout the year and then submit it during a specific submission window (e.g., February 1 \- March 31 of the following year).  
* **Bulk Uploads and File Format:** The primary method for large-scale data submission is a bulk upload of a highly structured `.csv` or `.xlsx` file. This file must adhere to a strict data mapping document provided by CMS. Any deviation in column headers, data types, or formatting will result in a submission failure. Your system must have a robust export function that generates a file in this exact format.  
* **Unique Identifiers:** The system relies on unique identifiers for matching. For physicians, this is the **National Provider Identifier (NPI)** number. For teaching hospitals, it is the Tax Identification Number (TIN). The system must be able to match the HCP in your database with these official numbers to ensure the data is correctly attributed. Your `Physician Verification API` feature is essential for this step.  
* **Attestation:** After the data is submitted, a company representative must "attest" to its accuracy and completeness via the CMS website. This is a legal certification that cannot be automated. Your system should generate the necessary reports and then alert the user that the final attestation step must be completed manually on the CMS portal.

### **3\. The UK's Voluntary Framework and its Limitations**

The UK represents a different regulatory model that your system must account for.

* **Voluntary, Not Mandatory:** Unlike the US and France, the UK's "Disclosure UK" system, managed by the Association of the British Pharmaceutical Industry (ABPI), is based on a **voluntary industry code** rather than a statutory law. Companies that are members of the ABPI are required to participate, but those outside the organization may not be.  
* **No Centralized Database:** While Disclosure UK is a central database for pharmaceutical companies, the medical device sector in the UK does not have a single, unified reporting portal. This means data from different companies may be scattered across various websites, creating a fragmented landscape.  
* **Challenges for Transparency:** The voluntary nature and lack of a central, mandatory identifier (like the US NPI) can make it difficult for regulators and the public to get a complete and accurate picture. Payments may be misattributed due to variations in how a recipient's name is entered, or payments may simply not be disclosed if the company is not a member of the relevant industry association.

Therefore, your system must be flexible enough to handle these different "levels" of enforcement and data requirements across different countries. While a US report requires a precise file for a government submission, a UK report may simply require a data export for a company's internal website or to an industry-managed portal. This flexibility is a key differentiator for a global platform.

### **Updated Business Requirements Document (BRD)**

**Project ID:** COM-TRANSP-001 **Project Name:** Physician Payment and Transparency Reporting System **Date:** October 7, 2025 **Purpose:** To develop a cloud-native, commercial software solution for pharmaceutical and medical device companies to track, report, and disclose payments and other transfers of value (ToV) to healthcare professionals (HCPs) and organizations (HCOs), ensuring compliance with global transparency regulations.

---

### **1\. Business Goals**

* **Ensure Regulatory Compliance:** Provide a solution that automates reporting to meet the requirements of various national and international transparency laws, including the U.S. Sunshine Act, the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code, and France's "Loi Bertrand". This is critical for avoiding penalties and legal consequences.  
* **Increase Operational Efficiency:** Reduce the manual burden on compliance and finance teams by automating data capture, categorization, and report generation.  
* **Enhance Data Accuracy and Trust:** Implement features that allow for data verification, dispute resolution, and public-facing transparency to build trust with regulators, HCPs, and the public.  
* **Support Global Operations:** The system must be scalable and flexible to handle multi-currency transactions and diverse country-specific reporting requirements, including the key distinction between **individual and aggregate disclosure**.

---

### **2\. Functional Requirements**

*Updates are bolded and bulleted within existing sections.*

#### **2.1 Core System Functions**

* **Payment & ToV Capture (via Payment Capture API):** The system must accept and process a variety of payment and transfer of value data from multiple sources.  
  * **REQ-001:** The system must track financial interactions, including consulting fees, speaking fees, honoraria, research grants, royalties, and travel and lodging expenses.  
  * **REQ-002:** The system must capture transaction details such as date, value, currency, and the specific HCP or HCO recipient.  
  * **REQ-003:** The system must automatically categorize each ToV based on pre-defined criteria (e.g., General Payment, Research Payment, Ownership/Investment Interest).  
  * **REQ-004:** The system must identify and tag non-reportable expenses, such as low-value meals (e.g., `< $10` per meal in the US) and drug samples, to prevent their inclusion in reports.  
  * **REQ-005:** The system must support the reporting of both monetary payments and in-kind transfers of value, such as meals or educational materials.  
* **HCP/HCO Data Management (via HCP Data Management feature):** The system must maintain a comprehensive and accurate database of covered recipients.  
  * **REQ-006:** The system must store and manage HCP data, including name, specialty, professional license number(s), and primary business address.  
  * **REQ-007:** The system must support the verification of HCP data against authoritative sources, such as the **National Provider Identifier (NPI)** database in the US, which is required for CMS reporting.  
  * **REQ-008:** The system must support a **broader range of recipients** as required by jurisdictions like France, including students in healthcare fields, nurses, and scientific societies.  
* **Compliance Rule Engine (via ToV Calculation API):** The system must apply specific rules for each reporting jurisdiction.  
  * **REQ-009:** The system must calculate the total value of payments made to each HCP and HCO for a given reporting period.  
  * **REQ-010:** The system must apply minimum reporting thresholds, such as the **$10 per-payment and $100 aggregate annual thresholds** under the US Sunshine Act. The system must also apply the **€10 threshold** for the French "Loi Bertrand".  
  * **REQ-011:** The system must support multi-currency transactions and convert all payment values to a single reporting currency (e.g., USD, EUR) using a defined exchange rate.  
* **Consent Management (via Physician Consent Management feature):** The system must manage and track HCP consent for public disclosure.  
  * **REQ-012:** The system must provide a mechanism for companies to obtain and record explicit consent from HCPs as required by regulations like the EFPIA Disclosure Code.  
  * **REQ-013:** The system must differentiate between disclosure types based on consent: **Individual Disclosure** (when consent is given) and **Aggregate Disclosure** (when consent is not given).  
  * **REQ-014:** The system must ensure that payments for **Research and Development (R\&D)** are automatically designated for aggregate disclosure, regardless of consent.  
* **Reporting & Submission (via Aggregate Reporting and CMS Open Payments APIs):** The system must generate compliant reports and facilitate submission to regulatory bodies.  
  * **REQ-015:** The system must generate reports that meet the specific formatting and data requirements for each jurisdiction, including **country-specific templates** and file formats (e.g., the exact `.csv` format required for CMS).  
  * **REQ-016:** The system must provide a secure and automated method for direct submission of data to the **CMS Open Payments** system in the United States, adhering to the annual **February 1st to March 31st submission window**.  
  * **REQ-017:** The system must generate a report for the client to use for the **final attestation** on the CMS portal, as this step cannot be automated.  
* **Dispute Resolution Workflow (via Dispute Resolution feature):** The system must facilitate a process for HCPs to review and dispute reported data.  
  * **REQ-018:** The system must provide HCPs with a review period (e.g., **45-day review period** in the US) to access and dispute their reported data before public release.  
  * **REQ-019:** The system must provide a clear workflow for companies and HCPs to communicate and resolve disputes, including the ability for the company to make corrections.  
* **Public Disclosure Website (via Disclosure Website Generation feature):** The system must generate a publicly accessible website to display reported data.  
  * **REQ-020:** The system must generate a website that complies with legal requirements for public disclosure, distinguishing between **individual-level data** (for jurisdictions like the US and France) and **aggregate-level data** (for the EU and for R\&D payments).  
  * **REQ-021:** The system must support the generation of disclosure reports for the **UK’s voluntary Disclosure UK** system.

---

### **3\. Non-Functional Requirements**

* **Security:** The system must be cloud-native and have robust security protocols to protect sensitive HCP data in compliance with privacy regulations like **GDPR**.  
* **Scalability:** The architecture must be scalable to handle a large volume of transactions and a growing number of HCPs and clients.  
* **Usability:** The user interface should be intuitive for compliance, finance, and sales teams to easily input, manage, and report data.  
* **Integration:** The system must be able to seamlessly integrate with a variety of external systems including CRM, expense, payroll, and event management systems via the defined APIs.  
* **Pricing:** The pricing model will be based on a "Per HCP interaction \+ reporting" structure. This must be a core component of the system's billing and usage tracking.

perfect now we need complete details of the rules, variations , etc

Show thinking

To build a truly robust system, you need to "double-click" further into the granular details and variations of each regulatory framework. Here is a more complete breakdown of the rules, including nuances and recent updates that a transparency reporting system must handle.

### **1\. U.S. Sunshine Act (Open Payments)**

**Core Principle:** A federally mandated law (part of the Affordable Care Act) requiring applicable manufacturers of drugs, devices, and biologics to report payments and transfers of value to covered recipients. The data is published annually on a public website by the Centers for Medicare & Medicaid Services (CMS).

#### **Key Details:**

* **Covered Recipients:**  
  * Physicians (doctors of medicine, osteopathy, dentists, podiatrists, optometrists, and chiropractors).  
  * **Crucial Update:** The **SUPPORT Act** expanded the definition to include Physician Assistants, Nurse Practitioners, Clinical Nurse Specialists, Certified Registered Nurse Anesthetists, and Certified Nurse Midwives. Your system must be able to track and report to these expanded categories.  
  * Teaching Hospitals.  
* **Reportable Payments/ToV:**  
  * **General Payments:** Fees for services (consulting, speaking), food and beverages, travel, gifts, honoraria, and educational materials. The **$10 per-payment** and **$100 aggregate annual threshold** are critical for flagging payments.  
  * **Research Payments:** Any payment made in connection with a research agreement, including grants and funding for clinical trials. These are reported under a separate category.  
  * **Ownership/Investment Interest:** Any equity, stock, or other ownership interest held by a physician or their immediate family member.  
  * **Indirect Payments:** The system must track payments made to a third party (e.g., a medical education company) if the payment is directed or intended for a specific covered recipient.  
* **Non-Reportable (Exempt) Payments:**  
  * Educational materials that are directly for patient use.  
  * Product samples intended for patient use.  
  * Discounts and rebates on products.  
  * Items of less than $10, unless the aggregate total to that recipient exceeds $100 annually.  
* **Reporting Cycle & Submission Nuances:**  
  * **Reporting Period:** Data is collected for a full calendar year (January 1 \- December 31).  
  * **Submission Window:** Applicable manufacturers must submit their data to CMS between February 1 and March 31 of the following year.  
  * **Dispute Resolution:** HCPs have a 45-day review period (usually from April to May) to review and dispute any reported data before final publication on June 30th.  
  * **Data Integrity:** CMS disallows record deletions without a substantiated reason. Your system's dispute workflow must handle record corrections and the justification for changes.

### **2\. EFPIA Disclosure Code (EU)**

**Core Principle:** A self-regulatory code adopted by EFPIA member companies. It emphasizes transparency in interactions with HCPs and Healthcare Organizations (HCOs), but is distinct from the US model due to its reliance on **consent** and the presence of numerous national variations.

#### **Key Details:**

* **Voluntary vs. Mandatory:** The EFPIA code itself is a self-regulatory commitment, but many member states have implemented national laws (e.g., in Portugal, France, and Denmark) that make disclosure mandatory. Your system needs to distinguish between these countries.  
* **Recipient Consent:** This is the most critical difference from the US. Companies must seek **freely given, specific, and unambiguous consent** from HCPs to individually disclose their data.  
  * **Individual Disclosure:** If consent is granted, the company publishes the named HCP and the value of the transfer.  
  * **Aggregate Disclosure:** If consent is not granted, the payment is reported in an aggregate sum alongside a count of the recipients.  
* **Reportable Payments/ToV:**  
  * **Direct Payments:** Fees for service, consultancy agreements, and payments for travel and accommodation to attend educational events.  
  * **Indirect Payments:** Transfers of value made via a third-party organization (e.g., a research institution or a conference organizer) are also reportable.  
  * **Donations and Grants:** Payments made to HCOs (not individuals) for research or educational purposes are reportable.  
  * **R\&D Exemption:** Payments for R\&D activities are generally disclosed on an **aggregate basis** to protect intellectual property and confidentiality.  
* **Non-Reportable (Exempt) Payments:**  
  * Inexpensive items of medical value.  
  * Meals and drinks, although national codes may set specific thresholds for these.  
  * Information and educational materials designed for patients.  
  * Over-the-counter medicine samples.  
* **Reporting Cycle & Submission Nuances:**  
  * **Reporting Period:** Annually, covering a full calendar year.  
  * **Publication Deadline:** The disclosure must be made public by June 30th of the following year.  
  * **Publication Platform:** In most countries, companies publish on their own website. However, some countries (e.g., France, Portugal, and Belgium) have national, governmental platforms where the data must be submitted. This variation is a significant design consideration for your system.

### **3\. French "Loi Bertrand"**

**Core Principle:** A mandatory, comprehensive transparency law that is broader than the US Sunshine Act in its scope of covered recipients and products.

#### **Key Details:**

* **Mandatory Disclosure:** All agreements and benefits must be publicly disclosed on a central government website, the "Transparence Santé" database.  
* **Covered Recipients:** This is a key point of differentiation. The law covers a very broad range of recipients, including:  
  * Physicians, pharmacists, nurses, and midwives.  
  * **Medical students.**  
  * **Scientific societies** and associations of healthcare professionals.  
  * **Consulting firms** that provide services to the healthcare sector.  
* **Reportable Payments/ToV:**  
  * Any benefit in cash or in-kind representing or exceeding **€10**.  
  * **All agreements**, including research and development contracts, consultancy agreements, and hospitality agreements for conventions.  
  * **No Obligation to Disclose:** A notable exception is that there is no obligation to disclose amounts for commercial sales agreements for goods and services.  
* **Submission & Publication:** Data for the first half of the year (Jan 1 \- June 30\) must be submitted by September 1st. Data for the second half of the year (July 1 \- Dec 31\) must be submitted by March 1st. The data is published for a period of five years.

### **4\. UK Disclosure UK**

**Core Principle:** A unique, voluntary, self-regulatory system managed by the Association of the British Pharmaceutical Industry (ABPI), acting as the UK's national implementation of the EFPIA Disclosure Code. There is no comprehensive, mandatory reporting law in the UK.

#### **Key Details:**

* **Voluntary Disclosure:** Disclosure UK is a central, voluntary database for the pharmaceutical industry. Participation is a requirement for ABPI members.  
* **Consent and Data Privacy:** Similar to the EFPIA model, the system is based on consent. Companies are "encouraged" to obtain consent for individual disclosure. If consent is not given, the value is published in an aggregated total.  
* **Recipient Categories:** The rules apply to HCPs and HCOs.  
* **What is Disclosed:**  
  * Payments for fees-for-service, sponsorship to attend meetings (travel, accommodation, registration), and grants/donations to HCOs.  
  * R\&D payments are reported in an aggregate lump sum, without individual recipient names.  
* **Variations:** Your system must be aware that other sectors, such as medical technology, do not have a single, unified reporting portal and may have to publish on their own company websites. There is no single, government-mandated system for all healthcare sectors.

![profile picture][image1]  


[image1]: <data:image/png;base64,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>